Literature DB >> 11268391

Possible function of IL-6 and TNF as intraadrenal factors in the regulation of adrenal steroid secretion.

A M Judd1, G B Call, M Barney, C J McIlmoil, A G Balls, A Adams, G K Oliveira.   

Abstract

Interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF alpha) and their mRNAs are present in the human, rat, and bovine adrenal cortex. The release of these cytokines from adrenal cells is regulated by factors that alter adrenal function (e.g., ACTH, angiotensin II, interleukin-1). IL-6 and TNF type 1 receptors are also present on adrenocortical cells. Exposure to IL-6 increases cortisol or corticosterone release from human, bovine, and rat adrenal cells. IL-6 increases basal and ACTH-stimulated aldosterone release, but inhibits angiotensin II-stimulated aldosterone secretion from bovine adrenal cells. IL-6 increases dehydroepiandrosterone (DHEA) release from human cells, but decreases DHEA secretion from bovine cells. TNF alpha inhibits corticosterone release from normal rat adrenal cells or fragments, but increases corticosterone release from cholestatic rat adrenal slices. TNF alpha decreases cortisol release from bovine and fetal human adrenal cells, but increases cortisol release from adult human adrenal cells. TNF alpha inhibits aldosterone secretion from rat and bovine adrenocortical cells. TNF alpha does not affect DHEA secretion from fetal human adrenocortical cells, but inhibits basal and ACTH-stimulated DHEA release from bovine adrenal cell. Because IL-6 and TNF alpha are produced in the adrenal gland and modify adrenal steroid secretion, these cytokines may function as intraadrenal factors in the regulation of adrenal steroid secretion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11268391     DOI: 10.1111/j.1749-6632.2000.tb05428.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  27 in total

1.  The brain Renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance.

Authors:  Justin L Grobe; Connie L Grobe; Terry G Beltz; Scott G Westphal; Donald A Morgan; Di Xu; Willem J de Lange; Huiping Li; Koji Sakai; Daniel R Thedens; Lisa A Cassis; Kamal Rahmouni; Allyn L Mark; Alan Kim Johnson; Curt D Sigmund
Journal:  Cell Metab       Date:  2010-11-03       Impact factor: 27.287

Review 2.  Endocrinology: the active partner in PNI research.

Authors:  William B Malarkey; Paul J Mills
Journal:  Brain Behav Immun       Date:  2006-12-15       Impact factor: 7.217

3.  Adrenal steroids in adrenomyeloneuropathy. Dehydroepiandrosterone sulfate, androstenedione and 17alpha-hydroxyprogesterone.

Authors:  Maria Wichers-Rother; Andreas Grigull; Piotr Sokolowski; Birgit Stoffel-Wagner; Wolfgang Köhler
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

Review 4.  The regulation of aldosterone secretion by leptin: implications in obesity-related cardiovascular disease.

Authors:  Jessica L Faulkner; Thiago Bruder-Nascimento; Eric J Belin de Chantemèle
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-03       Impact factor: 2.894

Review 5.  Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.

Authors:  Marni N Silverman; Brad D Pearce; Christine A Biron; Andrew H Miller
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

6.  Cortisol level after dexamethasone suppression test in patients with non-functioning adrenal incidentaloma is positively associated with the duration of reactive hyperemia response on microvascular bed.

Authors:  M P de Paula; A B Moraes; M das Graças Coelho de Souza; E M R Cavalari; R C Campbell; G da Silva Fernandes; M L F Farias; L M C Mendonça; M Madeira; E Bouskela; L G Kraemer-Aguiar; L Vieira Neto
Journal:  J Endocrinol Invest       Date:  2020-07-19       Impact factor: 4.256

7.  Defining normal adrenal function testing in the intensive care unit setting: a canine study.

Authors:  Daniel A Sweeney; Charles Natanson; Steven M Banks; Steven B Solomon; Ellen N Behrend
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

8.  Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  R H Straub; C Weidler; B Demmel; M Herrmann; F Kees; M Schmidt; J Schölmerich; J Schedel
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

Review 9.  Functioning adrenocortical oncocytoma: the first documented case producing interleukin-6 and review of the literature.

Authors:  T Akatsu; K Kameyama; K Araki; T Ashizawa; G Wakabayashi; M Kitajima
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

10.  Serum interleukin-6 predicts cortisol release in acute stroke patients.

Authors:  A Szczudlik; T Dziedzic; S Bartus; A Slowik; A Kieltyka
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.